{"id":910674,"date":"2025-11-17T08:35:44","date_gmt":"2025-11-17T13:35:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/"},"modified":"2025-11-17T08:35:44","modified_gmt":"2025-11-17T13:35:44","slug":"madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/","title":{"rendered":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CONSHOHOCKEN, Pa., Nov.  17, 2025  (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference in London<\/strong><br \/>\n        <br \/>Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET)<br \/>The presentation will be webcast live and may be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5q8B0IA-Zxnz2caHZ5A4Jrv93Hw4jkj1NKiKWkqxi1RsBi1OS3wQbGNYTISz00fjorKw1xLBoDh07OQ9Bv60K4MlEKjNUaUNd2j1tZM23qI=\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong>8th Annual\u00a0Evercore Healthcare Conference<\/strong><br \/>\n        <br \/>Tuesday, Dec. 2, 2025 at 4:15 P.M. ET<br \/>The presentation will be webcast live and may be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5q8B0IA-Zxnz2caHZ5A4JpPpRoYpdJFRIcr20icdfgeR5AoUGPOp3SV8PjoRZq7Gv3kaaOQui0OJ8XHXLo0UQxILnN1TnwWT8gsUxFEWD8M=\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong>Piper Sandler 37<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong><br \/>\n        <br \/>Wednesday, Dec. 3, 2025 at 1:30 P.M. ET<br \/>The presentation will be webcast live and may be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5q8B0IA-Zxnz2caHZ5A4Jg6iZ7GMzt1dMXEiHqrJWdvupW-y6XdhRcL4Ph_Lyasjlq19trxPWzd9y-4dM-aMV902HNByWJlo2fA0yf6A5xFGzh1LUt7CcFzwmz3Ecl75T25zVQxTc8FbypWp45TetQ==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>The fireside chats will be webcast live and can be accessed by visiting Madrigal\u2019s Investor Relations Events\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xcOtPNm4aIHyWD-11fNUEQFui2diNoXto_HXmjpSxDAJcXaw5ZBZU8RPVnzPI9bjzf5BhUAJ76o_Vi6Z6HbLqrxtzjjyuodTT7ojp2e1HeOHRag1wJMNKjzaOa8Ko6s84I0xrxX1mIf_uZQ53dbEvUPvcAoSU2OPnRUBhJdORwSS-paNoONReFNAyMI14iAkGiqiMZHb1afcquJ_zorS1ItNa3xAUQW6_mZYsT79-xlQVnIhT09ykiFPmYMChky4nok8jG-X7Kpmwb1WcYB_PA==\" rel=\"nofollow\" target=\"_blank\">page<\/a>.<\/p>\n<p>\n        <strong>About Madrigal<\/strong><br \/>\n        <br \/>Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal\u2019s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-\u03b2 agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f4wbFTDPtQcyn04DreCDnOqQFG7mDG0Ax4u5OR5InjReqKjuzOND7-BKM8XuGmYOIqzpkhqe7ZOmQAHjh3tfFHNxaF25f0Jsu04RwqVlvYMspaJy9LIsr7n31Vjc0bT10NfownnPEXdobN5WOQog51whPa-m1mtMXZyzX8YM_4sMAClqY2Zs7Dpv6JnVlzwB6X1WvUroznduh0JPnzmJJi7eRD7nBmNn_pf3V8pf_X6b0vigov-UgxC4YEr3xa73GUtiWP_xgpDLEYXkSgxiWg==\" rel=\"nofollow\" target=\"_blank\">www.madrigalpharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact <\/strong><br \/>\n        <br \/>Tina Ventura, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2nWyX4JI3VGM9fsKqszFBRQO8lFpAykxA4qHWyEIrLXsyDiGkQVLeSeMBGXexEngtGmk-vB6NIVcaT27MBYZmtlzg4_M-wHgV0PNYXp7V2s=\" rel=\"nofollow\" target=\"_blank\">IR@madrigalpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Christopher Frates, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QCCs9NwFtjzr-jN5ok0rGRE2-pgWhW4LRhIIkg2FpYxG4tD5Z5R6bftdyE6TuAAdDbw1F--LvSQgOC24oHMtcEwYJhYhJPWOLhBL_fNQ-oGb6lG0kwv1MMw58xA4EcXN\" rel=\"nofollow\" target=\"_blank\">media@madrigalpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzY2Yjc2OTQtOGNiNi00OWVjLWJmNWQtMzQ2ZmNlNThjOTEyLTEwMTc3ODYtMjAyNS0xMS0xNy1lbg==\/tiny\/Madrigal-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: Jefferies Global Healthcare Conference in London Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET)The presentation will be webcast live and may be accessed here. 8th Annual\u00a0Evercore Healthcare Conference Tuesday, Dec. 2, 2025 at 4:15 P.M. ETThe presentation will be webcast live and may be accessed here. Piper Sandler 37 th Annual Healthcare Conference Wednesday, Dec. 3, 2025 at 1:30 P.M. ETThe presentation will be webcast live and may be accessed here. The fireside chats will be webcast live and can be accessed by visiting Madrigal\u2019s Investor Relations Events\u00a0page. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-910674","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: Jefferies Global Healthcare Conference in London Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET)The presentation will be webcast live and may be accessed here. 8th Annual\u00a0Evercore Healthcare Conference Tuesday, Dec. 2, 2025 at 4:15 P.M. ETThe presentation will be webcast live and may be accessed here. Piper Sandler 37 th Annual Healthcare Conference Wednesday, Dec. 3, 2025 at 1:30 P.M. ETThe presentation will be webcast live and may be accessed here. The fireside chats will be webcast live and can be accessed by visiting Madrigal\u2019s Investor Relations Events\u00a0page. About &hellip; Continue reading &quot;Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-17T13:35:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences\",\"datePublished\":\"2025-11-17T13:35:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/\",\"name\":\"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\",\"datePublished\":\"2025-11-17T13:35:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","og_description":"CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: Jefferies Global Healthcare Conference in London Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET)The presentation will be webcast live and may be accessed here. 8th Annual\u00a0Evercore Healthcare Conference Tuesday, Dec. 2, 2025 at 4:15 P.M. ETThe presentation will be webcast live and may be accessed here. Piper Sandler 37 th Annual Healthcare Conference Wednesday, Dec. 3, 2025 at 1:30 P.M. ETThe presentation will be webcast live and may be accessed here. The fireside chats will be webcast live and can be accessed by visiting Madrigal\u2019s Investor Relations Events\u00a0page. About &hellip; Continue reading \"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-17T13:35:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences","datePublished":"2025-11-17T13:35:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/","name":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=","datePublished":"2025-11-17T13:35:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NjM5MCM3MjY1OTcyIzIwMDYyMTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/madrigal-pharmaceuticals-announces-participation-at-three-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=910674"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910674\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=910674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=910674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=910674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}